Overview

Progesterone in Threatened Abortion

Status:
Terminated
Trial end date:
2018-05-02
Target enrollment:
Participant gender:
Summary
The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg/bid in the maintenance of early pregnancy in women with symptoms of threatened abortion. The secondary objectives will be the efficacy of progesterone in reducing both pain and uterine contractions.
Phase:
Phase 3
Details
Lead Sponsor:
IBSA Institut Biochimique SA
Treatments:
Progesterone